Ginkgo Bioworks Acquires Proof Diagnostics
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Jonathan Gootenberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
BOSTON, Feb. 28, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, announced the acquisition of Proof Diagnostics, an...
A system that edits RNA rather than DNA can give new life to exhausted CAR T cells. A system that edits RNA rather than DNA can give new life to exhausted CAR T cells.
Advances in artificial intelligence are at the heart of many of this year’s most exciting areas of technological innovation Advances in artificial intelligence are at the heart of many of this year’s most exciting areas of technological innovation